We are live on
!
Find out more
CIC
Crawford Investment Counsel Portfolio holdings
AUM
$5.85B
1-Year Est. Return
12.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.09%
1 Year Est. Return
+12.61%
3 Year Est. Return
+44.31%
5 Year Est. Return
+59.61%
10 Year Est. Return
+1,024.8%
AUM
$3.17B
AUM Growth
-$48.6M
(-1.5%)
Cap. Flow
+$37M
Cap. Flow
% of AUM
1.17%
Top 10 Holdings %
Top 10 Hldgs %
25.12%
Holding
265
New
13
Increased
118
Reduced
84
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$35.1M |
| 2 |
Visa
V
|
+$30.2M |
| 3 |
Coca-Cola
KO
|
+$28.2M |
| 4 |
Procter & Gamble
PG
|
+$17M |
| 5 |
TotalEnergies
TTE
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$44.4M |
| 2 |
SAP
SAP
|
+$37.7M |
| 3 |
Fidelity National Information Services
FIS
|
+$23.4M |
| 4 |
Microsoft
MSFT
|
+$12.4M |
| 5 |
ExxonMobil
XOM
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.62% |
| 2 | Technology | 15.63% |
| 3 | Healthcare | 13.32% |
| 4 | Industrials | 11.77% |
| 5 | Consumer Staples | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Philip Morris
PM
$290B
| $55.6M | 1.75% |
559,229
+112,250
| +25% | +$11.7M |
|
27
Cullen/Frost Bankers
CFR
$10.3B
| $54.7M | 1.73% |
515,956
+36,735
| +8% | +$3.84M |
|
28
Northern Trust
NTRS
$34.3B
| $54.2M | 1.71% |
525,947
-14,985
| -3% | -$1.57M |
|
|
29
ExxonMobil
XOM
$657B
| $52.8M | 1.66% |
707,423
-138,855
| -16% | -$11.1M |
|
30
MetLife
MET
$61.7B
| $50.4M | 1.59% |
1,098,289
+47,231
| +4% | +$2.29M |
|
31
Johnson Controls International
JCI
$93.3B
| $46.8M | 1.48% |
1,328,071
+327,200
| +33% | +$12.4M |
|
32
Cardinal Health
CAH
$56.2B
| $45.9M | 1.45% |
732,590
+184,492
| +34% | +$12.7M |
|
33
McCormick & Company Non-Voting
MKC
$14.2B
| $44.7M | 1.41% |
839,886
+25,686
| +3% | +$1.35M |
|
|
34
Visa
V
$677B
| $43.2M | 1.36% |
361,075
+249,478
| +224% | +$30.2M |
|
35
RTX Corp
RTX
$302B
| $41.4M | 1.31% |
523,146
-7,072
| -1% | -$584K |
|
36
Chubb
CB
$134B
| $40.3M | 1.27% |
294,469
+5,958
| +2% | +$863K |
|
37
Hubbell
HUBB
$27.3B
| $38.1M | 1.2% |
312,570
+9,563
| +3% | +$1.26M |
|
38
S&P Global
SPGI
$120B
| $35.9M | 1.13% |
187,840
-1,163
| -0.6% | -$215K |
|
|
39
TotalEnergies
TTE
$196B
| $33M | 1.04% |
52,436,804
+24,668,473
| +89% | +$15.4M |
|
40
Walmart Inc
WMT
$898B
| $28.3M | 0.89% |
952,887
+16,185
| +2% | +$521K |
|
41
Cisco
CSCO
$475B
| $26.7M | 0.84% |
622,198
-66,028
| -10% | -$2.8M |
|
|
42
Fidelity National Information Services
FIS
$22.1B
| $24.4M | 0.77% |
253,354
-238,854
| -49% | -$23.4M |
|
43
GSK
GSK
$102B
| $23.3M | 0.73% |
476,432
+64,792
| +16% | +$3.02M |
|
44
Cracker Barrel
CBRL
$1.27B
| $23.2M | 0.73% |
145,544
-6,876
| -5% | -$1.14M |
|
45
Perrigo
PRGO
$1.76B
| $22.5M | 0.71% |
269,512
+18,181
| +7% | +$1.59M |
|
46
Verizon
VZ
$196B
| $20.6M | 0.65% |
431,016
+2,642
| +0.6% | +$133K |
|
47
Wells Fargo
WFC
$265B
| $19.9M | 0.63% |
379,157
-35,963
| -9% | -$2.14M |
|
48
Altria Group
MO
$108B
| $18.9M | 0.59% |
302,498
+1,214
| +0.4% | +$80.4K |
|
49
Watsco Inc
WSO
$13.3B
| $18.2M | 0.57% |
100,733
-32,786
| -25% | -$5.68M |
|
50
Flowers Foods
FLO
$1.52B
| $17.5M | 0.55% |
799,977
-130,036
| -14% | -$2.63M |
|
Similar funds
LIP
BSL
SC
MWM
WAM
PP
CGPCS
AL
Crawford Investment Counsel's Q1 2018 Portfolio in Review
As of Q1 2018, Crawford Investment Counsel held 265 positions worth $3.17B, down 1.5% from $3.22B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Crawford Investment Counsel's Q1 2018 filing shows 13 new, 118 increased, 84 reduced and 7 closed positions. Its largest new stake was Mid-America Apartment Communities: 49,267 shares worth $4.5M. The largest sale was CVS Health, an estimated $44.4M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.
- Crawford Investment Counsel's largest Q1 2018 buy was Mid-America Apartment Communities: 49,267 shares worth $4.5M.
- Crawford Investment Counsel added most to AstraZeneca in Q1 2018, an estimated $35.1M increase.
- Crawford Investment Counsel's biggest Q1 2018 reduction was CVS Health, cutting an estimated $44.4M.
- Crawford Investment Counsel fully exited DST Systems Inc. in Q1 2018, selling an estimated $2.11M.
- Crawford Investment Counsel's ten largest holdings make up 25% of its $3.17B portfolio in Q1 2018.
- Crawford Investment Counsel opened 13 new positions and closed 7 in Q1 2018.
- Crawford Investment Counsel's portfolio value fell 1.5% quarter-over-quarter to $3.17B.
Based on Crawford Investment Counsel's 13F filing for Q1 2018, filed 15 May 2018.